BR0010969A - Multipurpose Dengue Virus Vaccine - Google Patents

Multipurpose Dengue Virus Vaccine

Info

Publication number
BR0010969A
BR0010969A BR0010969-0A BR0010969A BR0010969A BR 0010969 A BR0010969 A BR 0010969A BR 0010969 A BR0010969 A BR 0010969A BR 0010969 A BR0010969 A BR 0010969A
Authority
BR
Brazil
Prior art keywords
dengue
virus
virus vaccine
multipurpose
dengue virus
Prior art date
Application number
BR0010969-0A
Other languages
Portuguese (pt)
Inventor
Kenneth Eckels
Joseph R Putnak
Doria R Dubois
Bruce L Innis
Charles H Hoke
Sun Wellington
Niranjan Kanesa-Thasan
Original Assignee
Us Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Army filed Critical Us Army
Priority claimed from PCT/US2000/008199 external-priority patent/WO2000057907A2/en
Publication of BR0010969A publication Critical patent/BR0010969A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"VACINA POLIVALENTE ANTIVìRUS DA DENGUE". A presente invenção formula composições de vacina de virus atenuado da dengue. Mais especificamente, o virus atenuado é produzido pela acomodação em sério nas células PDK. A invenção também formula métodos para estimular o sistema imunológico do indivíduo a fim de induzir proteção contra os todos os quatro sorotipos de vírus da dengue através da administração de virus atenuados dengue-1, dengue-2, dengue-3 e dengue-4."DENGUE ANTI-VIRUS ANTI-VIRUS VACCINE". The present invention formulates attenuated dengue virus vaccine compositions. More specifically, attenuated virus is produced by serious accommodation in PDK cells. The invention also formulates methods for stimulating the individual's immune system to induce protection against all four dengue virus serotypes by administering attenuated dengue-1, dengue-2, dengue-3 and dengue-4 viruses.

BR0010969-0A 2000-03-24 2000-03-24 Multipurpose Dengue Virus Vaccine BR0010969A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/008199 WO2000057907A2 (en) 1999-03-26 2000-03-24 Multivalent dengue virus vaccine

Publications (1)

Publication Number Publication Date
BR0010969A true BR0010969A (en) 2003-12-23

Family

ID=31493872

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010969-0A BR0010969A (en) 2000-03-24 2000-03-24 Multipurpose Dengue Virus Vaccine

Country Status (1)

Country Link
BR (1) BR0010969A (en)

Similar Documents

Publication Publication Date Title
Gritsun et al. Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis
Carneiro et al. The green tea molecule EGCG inhibits Zika virus entry
Diagana et al. Japanese encephalitis revisited
Nedjadi et al. Tackling dengue fever: Current status and challenges
AU2017250696A1 (en) Compositions and methods of vaccination against dengue virus in children and young adults
ATE419006T1 (en) MULTIVALENT DENGUE VIRUS VACCINE
MX2009012299A (en) Antiviral drugs for treatment or prevention of dengue infection.
BR0111732A (en) 2-Deoxy beta-1-nucleoside prodrugs
MY180698A (en) Immunization protocol against the 4 dengue serotypes
Mir et al. Identification of bioflavonoid as fusion inhibitor of dengue virus using molecular docking approach
US7790173B2 (en) Pharmaceutical compound capable of induce immune protective response against Dengue virus having the capsid protein of the Dengue virus
MX338530B (en) Small molecule inhibitors for the treatment or prevention of dengue virus infection.
JP2010505801A5 (en)
MY169275A (en) Method of immunization against the four serotypes of dengue
BRPI0010612B8 (en) vaccines
PE20140646A1 (en) INACTIVATED DENGUE VIRUS VACCINE
JP2002540168A5 (en)
CA2331368A1 (en) Nucleic acid vaccines for prevention of flavivirus infection
JP2016504315A5 (en)
Roberts et al. New opportunities for control of dengue virus
Alkafaas et al. A study on the effect of natural products against the transmission of B. 1.1. 529 Omicron
George et al. Antiviral activity of a standardized root water extract of Eurycoma longifolia (Physta®) against dengue virus.
BR0010969A (en) Multipurpose Dengue Virus Vaccine
Othman et al. Immunology and controlling of coronaviruses; the current enemy for humanity: A review
Pal Dengue fever: An emerging and re-emerging viral disease of major public health importance

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 17A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]